Medicina

2017

1. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)

   European Journal of Heart Failure, Vol. 19, Núm. 1, pp. 9-42

2. 2016 update of the EULAR recommendations for the management of early arthritis

   Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 948-959

3. 2017 ESC/EACTS Guidelines for the management of valvular heart disease

   European Heart Journal, Vol. 38, Núm. 36, pp. 2739-2786

4. 9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System

   JACC: Cardiovascular Interventions, Vol. 10, Núm. 2, pp. 160-167

5. A 30-month worksite-based lifestyle program to promote cardiovascular health in middle-aged bank employees: Design of the TANSNIP-PESA randomized controlled trial

   American Heart Journal, Vol. 184, pp. 121-132

6. A European multicientre study on the comparison of HBV viral loads between VERIS HBV assay and Roche COBAS® TAQMAN® HBV test, Abbott RealTime HBV assay, Siemens VERSANT HBV assay, and Qiagen artus HBV RG kit

   Journal of Clinical Virology, Vol. 95, pp. 76-83

7. A European multicientre study on the comparison of HIV-1 viral loads between VERIS HIV-1 Assay and Roche COBAS® TAQMAN® HIV-1 test, Abbott RealTime HIV-1 Assay, and Siemens VERSANT HIV-1 Assay

   Journal of Clinical Virology, Vol. 92, pp. 75-82

8. A Girl with Gray Hair and Pyogenic Infections

   Pediatric Dermatology, Vol. 34, Núm. 5, pp. 607-608

9. A Mediterranean diet with additional extra virgin olive oil and pistachios reduces the incidence of gestational diabetes mellitus (GDM): A randomized controlled trial: The St. Carlos GDM prevention study

   PLoS ONE, Vol. 12, Núm. 10

10. A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma

    Journal of Molecular Diagnostics, Vol. 19, Núm. 1, pp. 99-106

11. A PAM50-based chemoendocrine score for hormone receptor-positive breast cancer with an intermediate risk of relapse

    Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3035-3044

12. A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis

    Kidney International Reports, Vol. 2, Núm. 5, pp. 800-810

13. A Reversible Cause of Acute Right Ventricular Failure After Heart Transplant

    Revista Espanola de Cardiologia, Vol. 70, Núm. 8, pp. 677-679

14. A RheuMetric physician checklist to quantitate levels of inflammation, damage and distress on 0-10 visual analogue scales

    Clinical and Experimental Rheumatology, Vol. 35, Núm. 5, pp. S21-S25

15. A combined large-scale meta-Analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 286-294

16. A consensus statement on the gender perspective in lung cancer

    Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 527-535

17. A data mining approach using cortical thickness for diagnosis and characterization of essential tremor /692/53/2421 /692/617/375/346 /129 /141 /123 article

    Scientific Reports, Vol. 7, Núm. 1

18. A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624

19. A focused review of gender differences in antithrombotic therapy

    Current Medicinal Chemistry, Vol. 24, Núm. 24, pp. 2576-2588

20. A lower baseline CD4/CD8 T-cell ratio is independently associated with immunodiscordant response to antiretroviral therapy in HIV-infected subjects

    Antimicrobial Agents and Chemotherapy, Vol. 61, Núm. 8